SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-20-000210
Filing Date
2020-05-13
Accepted
2020-05-13 16:39:53
Documents
46
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDING MARCH 31, 2020 bivi-20200331_10q.htm 10-Q 335392
2 EXHIBIT 10.1 bivi-20200331_10qex10z1.htm EX-10.1 501
3 EXHIBIT 31.1 bivi-20200331_10qex31z1.htm EX-31.1 11828
4 EXHIBIT 31.2 bivi-20200331_10qex31z2.htm EX-31.2 11977
5 EXHIBIT 32.1 bivi-20200331_10qex32z1.htm EX-32.1 5002
6 EXHIBIT 32.2 bivi-20200331_10qex32z2.htm EX-32.2 4845
7 GRAPHIC image_001.jpg GRAPHIC 68530
  Complete submission text file 0001520138-20-000210.txt   2092760

Data Files

Seq Description Document Type Size
8 XBRL PRESENTATION FILE bivi-20200331_pre.xml EX-101.PRE 145145
9 XBRL SCHEMA FILE bivi-20200331.xsd EX-101.SCH 26134
10 XBRL INSTANCE FILE bivi-20200331.xml EX-101.INS 326255
11 XBRL CALCULATION FILE bivi-20200331_cal.xml EX-101.CAL 31609
12 XBRL DEFINITION FILE bivi-20200331_def.xml EX-101.DEF 73981
13 XBRL LABEL FILE bivi-20200331_lab.xml EX-101.LAB 197932
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39015 | Film No.: 20873706
SIC: 2834 Pharmaceutical Preparations